Skip to main content
Log in

Neuroonkologie

  • Weiterbildung: Zertifizierte Fortbildung
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Innerhalb des zentralen und peripheren Nervensystems entwickelt sich eine große Vielzahl von Tumoren mit sehr unterschiedlicher Inzidenz, Altersbevorzugung und Prognose. Zudem ist das Nervensystem sehr häufig von der Metastasierung systemischer Tumorerkrankungen betroffen. Die wesentlichen Therapiemodalitäten sind die Operation, die Strahlentherapie mit verschiedenen Konzepten der Fraktionierung, der Gesamtdosis und des Zielvolumens sowie verschiedene Ansätze der Chemotherapie wie systemische, interstitielle und intrathekale Chemotherapie und Hochdosischemotherapie mit Stammzelltransplantation. Dass viele dieser Therapieansätze nicht mehr nur einen palliativen, sondern einen kurativen Therapieansatz verfolgen, verdeutlicht, dass in der Neuroonkologie derzeit viele klassische Therapiekonzepte überdacht und innovative Strategien in die Therapie eingeführt werden.

Abstract

The central and peripheral nervous systems give rise to a variety of tumors which differ markedly in their incidence, age preference, and prognosis. The nervous system is also frequently affected by metastatic cancer. The major therapeutic options for tumors of the nervous system include surgical resection, radiotherapy using various strategies of fractionation, total dose, and target volume, and different approaches of chemotherapy such as systemic, intrathecal, and interstitial chemotherapy as well as high-dose chemotherapy with stem cell rescue. An increasing number of therapeutic options in neurooncology are no more merely palliative treatments, but may be curative, indicating that neurooncology is experiencing an era both of controversies regarding previous standards of care and of innovative strategies to combat tumors of the nervous system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Brandt T, Dichgans J, Diener HC (2003) Therapie und Verlauf neurologischer Erkrankungen. Kohlhammer, München

  2. Davis FG, McCarthy BJ, Freels S et al. (1999) The conditional probability of survival of patients with primary malignant brain tumors. Surveillance, epidemiology, and end results (SEER) data. Cancer 85:485–491

    Article  CAS  PubMed  Google Scholar 

  3. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114–122

    Article  CAS  PubMed  Google Scholar 

  4. Diener HC, Hacke W (2003) Leitlinien der Deutschen Gesellschaft für Neurologie. Thieme, Stuttgart

  5. Glioma Meta-analysis Trialists (GMT) Group (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011–1018

    Article  PubMed  Google Scholar 

  6. Herrlinger U, Felsberg J, Küker W et al. (2002) Gliomatosis cerebri. Molecular pathology and clinical course. Ann Neurol 52:390–399

    Article  CAS  PubMed  Google Scholar 

  7. Herrlinger U, Schabet M, Brugger W et al. (2002) German cancer society neuro-oncology group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 51:247–252

    CAS  PubMed  Google Scholar 

  8. Karim AB, Afra D, Cornu P et al. (2002) Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52:316–324

    Article  PubMed  Google Scholar 

  9. Kleihues P, Cavenee WK (2000) World Health Organization classification of tumours. Pathology & genetics. Tumours of the nervous system. IARC Press, Lyon

  10. Kondziolka D, Lunsford D, McLaughlin MR, Flickinger JC (1998) Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 339:1426–1433

    Article  CAS  PubMed  Google Scholar 

  11. Macdonald DR, Cascino TL, Schold SC, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280

    CAS  PubMed  Google Scholar 

  12. Neuro-Oncology Oncology Group (NOA) of the German Cancer Society (2003) Neuro-Oncology Working Group (NOA)-01 trial of radiotherapy plus adjuvant ACNU/VM26 versus ACNU/Ara-C chemotherapy for malignant glioma. J Clin Oncol 21:3276–3284

    Article  PubMed  Google Scholar 

  13. Pels H, Schmidt-Wolf IGH, Glasmacher A et al. (in press) Primary CNS lymphoma: Results of a pilot/phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol

  14. Reifenberger G, Louis DN (2003) Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62:111–126

    CAS  PubMed  Google Scholar 

  15. Schlegel U, Weller M, Westphal M (2003) Neuro-Onkologie. Thieme, Stuttgart

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Weller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weller, M. Neuroonkologie. Nervenarzt 74, 1139–1149 (2003). https://doi.org/10.1007/s00115-003-1645-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-003-1645-8

Schlüsselwörter

Keywords

Navigation